Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Adrenocorticotropic Hormone Receptor pipeline drugs market research report provides comprehensive information on the Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) targeted therapeutics development with respective active and dormant or discontinued projects.
ACTHR Pipeline Drugs Market Segmentation by Therapy Areas
Some of the key therapy areas of the ACTHR pipeline drugs market are hormonal disorders, central nervous system, genito-urinary system and sex hormones, and metabolic disorders.
ACTHR Pipeline Drugs Market Analysis, by Therapy Areas
For more ACTHR pipeline drugs market therapy areas insights, download a free report sample
ACTHR Pipeline Drugs Market Segmentation by Mechanisms of Action
The key mechanisms of action of the ACTHR pipeline drugs market are Adrenocorticotropic Hormone Receptor Agonist and Adrenocorticotropic Hormone Receptor Antagonist.
ACTHR Pipeline Drugs Market Analysis, by Mechanisms of Action
For more ACTHR pipeline drugs market MOA insights, download a free report sample
ACTHR Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the ACTHR pipeline drugs market are intramuscular, oral, parenteral, and subcutaneous.
ACTHR Pipeline Drugs Market Analysis, by Routes of Administration
For more ACTHR pipeline drugs market ROA insights, download a free report sample
ACTHR Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the ACTHR pipeline drugs market are small molecule, synthetic peptide, and peptide.
ACTHR Pipeline Drugs Market Analysis, by Molecule Types
For more ACTHR pipeline drugs market molecule type insights, download a free report sample
ACTHR Pipeline Drugs Market - Competitive Landscape
Some of the leading companies in the ACTHR pipeline drugs market are Crinetics Pharmaceuticals Inc, Ferring Pharmaceuticals Inc, Mallinckrodt Plc, OMass Therapeutics Limited, and Upsher-Smith Laboratories LLC.
ACTHR Pipeline Drugs Market Analysis, by Companies
To know more about the companies in the ACTHR pipeline drugs market, download a free report sample
ACTHR Pipeline Drugs Market Report Overview
Key Therapy Areas | Hormonal Disorders, Central Nervous System, Genito-Urinary System and Sex Hormones, and Metabolic Disorders |
Key Mechanisms of Action | Adrenocorticotropic Hormone Receptor Agonist and Adrenocorticotropic Hormone Receptor Antagonist |
Key Routes of Administration | Intramuscular, Oral, Parenteral, and Subcutaneous |
Key Molecule Types | Small Molecule, Synthetic Peptide, and Peptide |
Leading Companies | Crinetics Pharmaceuticals Inc, Ferring Pharmaceuticals Inc, Mallinckrodt Plc, OMass Therapeutics Limited, and Upsher-Smith Laboratories LLC |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R).
- Reviews of Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which includes product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key players involved in Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) targeted therapeutics and enlists all their major and minor projects.
- Assessment of Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) targeted therapeutics based on MoA, RoA, and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) targeted therapeutics.
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or ACTHR or MC2R) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Ferring Pharmaceuticals Inc
Mallinckrodt Plc
OMass Therapeutics Limited
Upsher-Smith Laboratories LLC
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas of the ACTHR pipeline drugs market?
The key therapy areas of the ACTHR pipeline drugs market are hormonal disorders, central nervous system, genito-urinary system and sex hormones, and metabolic disorders.
-
What are the key mechanisms of action of the ACTHR pipeline drugs market?
The key mechanisms of action of the ACTHR pipeline drugs market are Adrenocorticotropic Hormone Receptor Agonist and Adrenocorticotropic Hormone Receptor Antagonist.
-
What are the key routes of administration in the ACTHR pipeline drugs market?
The key routes of administration in the ACTHR pipeline drugs market are intramuscular, oral, parenteral, and subcutaneous.
-
What are the key molecule types in the ACTHR pipeline drugs market?
The key molecule types in the ACTHR pipeline drugs market are small molecule, synthetic peptide, and peptide.
-
Which are the leading companies in the ACTHR pipeline drugs market?
Some of the leading companies in the ACTHR pipeline drugs market are Crinetics Pharmaceuticals Inc, Ferring Pharmaceuticals Inc, Mallinckrodt Plc, OMass Therapeutics Limited, and Upsher-Smith Laboratories LLC.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.